Latest news about Bristol Myers Squibb
ShareThere has been 17 news about Bristol Myers Squibb in the past from 7 different sources and amongst 2 sections
These are the latest:
CNBC News
FDA approves Bristol Myers Squibb's schizophrenia drug, the first new type of treatment in decades
Read 
Fri, Oct 04, 2024
Quartz
The FDA just approved Bristol Myers Squibb's groundbreaking schizophrenia treatment
Read
Fri, Sep 27, 2024
CNBC News
Bristol Myers Squibb beats earnings estimates, raises outlook as drugmaker slashes costs
Read
Mon, Jul 29, 2024
CNBC News
Judge rejects J&J, Bristol Myers Squibb challenges to Medicare drug-price negotiations
Read
Tue, Apr 30, 2024
The Hill
Judge tosses Medicare drug negotiation challenges from Bristol Myers Squibb, Johnson & Johnson
Read
Tue, Apr 30, 2024
CNBC News
Bristol Myers Squibb beats on revenue, launches $1.5 billion cost cuts as it posts quarterly loss
Read
Thu, Apr 25, 2024
CNBC News
Healthy Returns: J&J cell therapy gains new edge over Bristol Myers rival
Read
Thu, Apr 11, 2024
CNBC News
J&J, Merck and Bristol Myers CEOs defend high drug prices in Senate hearing, as Biden tries to cut costs
Read
Thu, Feb 08, 2024
CNBC News
Bristol Myers Squibb results top estimates as new drugs post strong sales growth
Read
Fri, Feb 02, 2024
Distribution by section
Distribution by publisher
Here are the top publishers amongst the 7 on this scope:
- CNBC News: 59%
- The Wall Street Journal: 12%
- Quartz: 6%
- The Hill: 6%
- Financial Times: 6%
- The New York Times: 6%
- Bloomberg: 6%
Details
This content can be used under the CC BY 4.0 license